Novel pyrrole derivatives are disclosed as A.beta..sub.42-lowering agents for the treatment and prevention of neurodegenerative disorders characterized by the formation or accumulation of amyloid plaques comprising the A.beta..sub.42 peptide.
Web www.patentalert.com
< Emulsion-Stabilized Preparation
> Method of using oral lipase inhibitors to reduce plasma ghrelin and to prevent weight regain
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT